Resveratrol: Biological Activities and Therapeutic Potential
Published: November 30, 2014
Authors
- Sanjai SaxenaDepartment of Biotechnology, Thapar University, Patiala, Punjab, India
- Anugya SrivastavaDepartment of Biotechnology, Thapar University, Patiala, Punjab, India
Keywords
Resveratrol, phytoalexin, cardiotonic, anti-cancer, anti-oxidant, antimicrobial
Abstract
Resveratrol is a polyphenolic flavonoid initially identified as a phytoalexin and as a major constituent of red wine. However interest in this molecule initially developed as a cardioprotective agent and in due course of time therapeutic actions came into limelight. This article explores the different therapeutic activities of Resveratrol and highlights their possible mode of action responsible for its therapeutic action. It becomes evident from this article that Resveratrol has a pharmacological agent that has widespread targets and therefore due emphasis on specific biological action need to be addressed using medicinal chemistry and quantitative structure activity relationships in developing new congeners of Resveratrol to be exploited as drugs.
References
- Balan, V., Miller, G.S., Kaplun, L., Balan, K., Chong, Z.Z., Li,F., Kaplun, A., VanBerkum, M.F., Arking, R., Freeman, D.C., Maiese, K., Tzivion, G. (2008): Life span extension and neuronal protection by Drosophila nicotinamidase. J Biol. Chem. 283:27810-27819. http://dx.doi.org/10.1074/jbc.M804681200
- Basly, J.P., Marre-Fournier, F., Le Bail, J.C., Habrioux, G., Chulia, A.J. (2000): Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci 66(9):769–77.
- Baur, J.A. and Sinclair, D.A. (2006): Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 5:493-506. http://dx.doi.org/10.1371/journal.pone.0064372
- Belguendouz, L., Fremont, L. and Linard, A. (1997): Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem.Pharmacol. 53: 1347–1355. http://dx.doi.org/10.1016/S0006-2952(96)00820-9
- Berardi, V., Ricci, F., Castelli, M., Galati, G., Risuleo, G., (2009): Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use. J. Exp. Clin. Canc. Res. 28: 96. http://dx.doi.org/10.1186/1756-9966-28-96.
- Bhat, K.P.L., Lantvit, D., Christov, K., Mehta, R.G., Moon, R.C., Pezzuto, J.M. (2001): Estrogenic and anti-estrogenic properties of resveratrol in mammary tumor models. Cancer Res 61(20):7456–63.
- Borra, M.T., Smith, B.C. and Denu, J.M. (2005): Mechanism of human SIRT1 activation by Resveratrol. J. Biol.Chem. 280(17): 17187-17195. http://dx.doi.org/10.1074/jbc.M501250200
- Campagna, M., Rivas, C. (2010): Antiviral activity of resveratrol. Biochem. Soc. T. 38: 50-53. http://dx.doi.org/10.1042/BST0380050
- Chan, M.M. Y. (2002): Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of skin. Biochemical Pharmacology 63: 99-104. http://dx.doi.org/10.1016/S0006-2952(01)00886-3
- Clement, M.V., Hirpara, J.L., Chawdhury, S.H. and Pervaiz, S. (1998): Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002.
- Constant, J. (1997): Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis 8(10):645–9.
- Cuendet, M., and Pezzuto, J. M. (2000): The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol. Drug Interact. 17: 109–157
- Culpitt, S.V., Rogers, D.F., Fenwick, P.S., Shah, P., De Matos, C., Russel,l R.E.K., Barnes, P.J., Donnelly, L.E. (2003): Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58(11):942–6
- Dercks, W., Creasy, L.L. (1989): Influence of fosetyl-A1 on phytoalexin accumulation in the Plasmoparaviticola-grapevine interaction. PhysiolMol Plant Pathol 34: 203–13.
- Docherty, J. J., Fu, M. M., Stiffler, B. S., Limperos,R J., Pokabla, C.M., DeLucia, A.L. (1999) : Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 43: 145-155. http://dx.doi.org/10.1016/S0166-3542(99)00042-X
- Docherty, J.J., McEwen, H.A., Sweet, T.J., Bailey, E. and Booth T.D. (2007): Resveratrol inhibition of Propionibacterium acnes. J. Antimicrob. Chemother. 59(6):1182-1184.
- Docherty, J.J., Sweet, T.J., Bailey, E., Faith, S.A., Booth, T. (2006): Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res. 72: 171–177. http://dx.doi.org/10.1016/j.antiviral.2006.07.004
- Evers, D.L., Wang, X., Huong, S.M., Huang, D.Y., Huang, E.S. (2004): 3, 4’, 5-Trihydroxytransstilbene resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. Antiviral Res. 63: 85–95.
- Fermont, L. (2000): Biological effects of resveratrol. Life Sci. 66: 663– 73. http://dx.doi.org/10.1016/S0024-3205(99)00410-5
- Gehm, B.D., McAndrews, J.M., Chien, P.Y., and Jameson, J .L. (1997): Resveratrol, a polyphenolic compound found in grapes and wine, is agonist for the estrogen receptor. ProcNatlAcadSci (USA) 94(25):14138–14143.
- Gentilli, M., Mazoit, J. X., Bouaziz, H., Fletcher, D., Casper, R. F., Benhamou, D., and Savouret, J. F. (2001) Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Sci. 68: 1317–1321. http://dx.doi.org/10.1016/S0024-3205(00)01018-3
- Goodwin, J.S. (1984): Immunologic effects of non-steroidal anti-inflammatory drugs. Am J Med. 77:7-15
- Gülçin, I., Alici, H.A., Cesur, M. (2005): Determination of in vitro antioxidant and radical scavenging activities of propofol. Chem Pharm Bull 53(3):281-285.
- Gupta, Y. K., Briyal, S., Chaudhary, G., (2002): Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol. Biochem. Be. 71: 245-249. http://dx.doi.org/10.1016/S0091-3057(01)00663-3
- Gusman, J., Malonne, H., and Atassi, G. (2001): A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22: 1111–1117. http://dx.doi.org/10.1093/carcin/22.8.1111
- Halliwell, B. (1997): Antioxidants in human health and disease. Annual Review in Nutrition 16: 33−50.
- Halliwell, B., and Gutteridge, J. M. C. (1990): Role of free radicals and catalytic metal ions in human disease: an overview. Methods in Enzymology 186: 1−85. http://dx.doi.org/10.1016/0076-6879(90)86093-B
- Hung, L.M., Chen, J.K., Haung, S.S., Lee,R.S. and Su M.J. (2000): Cardioprotective effect of resveratrol – a natural anti-oxidant derived from grapes. Cardiovascular Research 47: 549-555. http://dx.doi.org/10.1016/S0008-6363(00)00102-4
- Jang, J.H., Surh Y.J. (2001): Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat phenochromocytoma. Mutat Res 496:181–190.
- Jang, M., C., Lining, Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C. W. W., Fong, H.H.S., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., Moon, R.C., Pezzuto, J.M. (1997): Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220. http://dx.doi.org/10.1126/science.275.5297.218
- Jeandet, P., Douillt- Breuil, A.C., Bessis, R., Deborel, S., Sbaghi, M. and Adrain, M. (2002): Phytoalexins from vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity and metabolism. J. Agric. Food Chem. 50: 2731-2741.
- Kapadia, G.J., Azuine, M.A., Tokuda, H., Takasaki, M., Mukainaka, T., Konoshima, T., Nishino, H. (2002): Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein–Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol. Res. 45: 499–505. http://dx.doi.org/10.1006/phrs.2002.0992
- Karuppagounder, S. S., Pinto, J. T., Xu, H., Chen, H.- L., Beal, M. F., Gibson, G. E., (2009): Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease. Neurochem. Int. 54: 111-118. http://dx.doi.org/10.1016/j.neuint.2008.10.008
- Kimura, Y., Okuda, H., and Arichi, S. (1985): Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim. Biophys. Acta 834: 275–278. http://dx.doi.org/10.1016/0005-2760(85)90167-5
- King RE, Kent KD, Bomser JA. 2005. Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. ChemBiol Interact 151(2):143–9. http://dx.doi.org/10.1016/j.cbi.2004.11.003
- Kutuk, O., Adli, M., Poli, G., Basaga, H. (2004): Resveratrol protects against 4-HNE induced oxidative stress and apoptosis in Swiss 3T3 fibroblasts. BioFactors 20(1):1–10.
- Langcake, P and Pryce, R. J. (1976). The production of resveratrol by Vitisvinifera and other members of the Vitaceae as a response to infection or injury. Physiological Plant Pathology, 9: 77–86. http://dx.doi.org/10.1016/0048-4059(76)90077-1
- Liu, Z.P., Li, W.X., Yu, B., Huang, J., Sun, J., Huo, J.S., Liu, C.X. (2005): Effects of transresveratrol from Polygonumcuspidatum on bone loss using the ovariectomized rat model. J Med Food 8(1):14–9. http://dx.doi.org/10.1089/jmf.2005.8.14
- Losa, G.A. (2003): Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells. Eur J Clin Invest 33(9):818–823. http://dx.doi.org/10.1046/j.1365-2362.2003.01219.x
- Lu, R., Serrero, G. (1999): Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 179(3):297–304.
- MacCarrone, M., Lorenzon, T., Guerrieri, P., and Agro, A. F. (1999): Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 265: 27–34
- Mahady, G. (2005): Resveratrol as an anti-bacterial agent. In Aggarwal, B and Shishodia S. (eds.) Resveratrol in health and disease. CRC Press, Boca Raton. http://dx.doi.org/10.1201/9781420026474.ch18
- Mahady, G.B. and Pendland, S.L. (2000): Resveratrol inhibits the growth of Helicobacter pylori in vitro. Am. J. Gasteroenterol 95:1849. http://dx.doi.org/10.1016/S0002-9270(00)00938-2
- Marambaud, P., Zhao, H., Davies, P., (2005): Resveratrol promotes clearance of Alzheimer’s disease amyloid-β peptides. J. Biol. Chem. 280: 37377-37382. http://dx.doi.org/10.1074/jbc.M508246200
- Mizutani, K., Ikeda, K., Kawai, Y., Yamori, Y. (1998): Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. BiochemBiophy Res Commun 253(3):859–863. http://dx.doi.org/10.1006/bbrc.1998.9870
- Mizutani, K., Ikeda, K., Yamori, Y. (2000): Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneous hypertensive rats. BiochemBiophy Res Commun 274(1):61–67. http://dx.doi.org/10.1006/bbrc.2000.3097
- Movahed, A., Nabipour, I., Louis X.L., Thandapilly, S.J., Yu, L., Kalantarhormozi, M., Rekebpour, S.J., Netticadan, T., (2013): Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evidence-Based Complementary and Alternative Medicine, Article ID 851267. http://dx.doi.org/10.1155/2013/851267
- Orallo, F., Alvarez, E., Camina, M., Leiro, J., Gomez, E., and Fernandez, P. (2002): Mol. Pharmacol. 61: 294-302.
- Palsamy, P., Subramanian, S. (2009): Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed. Pharmacother. 62: 598–605. http://dx.doi.org/10.1016/j.biopha.2008.06.037
- Paul, B., Masih, I., Deopujari, J. and Charpentier, C. (1999): Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India. J Ethnopharmacol 68: 71-76. http://dx.doi.org/10.1016/S0378-8741(99)00044-6
- Pendurthi, U.R., Williams, J.T., Rao, L.V.M. (1999): Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: a possible mechanism for the cardiovascular benefits associated with moderate wine consumption. ArteriosclerThrombVascBiol 19(2):419–26.
- Pervaiz, S. (2003): Resveratrol: from grapevines to mammalian biology. FASEB 17: 1975-1985. http://dx.doi.org/10.1096/fj.03-0168rev
- Plescia, O.J., Smith, A.H., Grinwich, K (1975): Subversion of immune system by tumor cells and role of prostaglandins. Proc. NatlAcadSci USA. 72(5) : 1848–1851
- Poussier, B., Cordova, A.C., Becquemine, J.P. and Sumpio, B.E. (2005): Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J. Vasc. Surg. 42: 1190–1197. http://dx.doi.org/10.1016j.jvs.2005.08.014
- Roman, V., Billard, C., Kern, C., Ferry-Dumazet, H., Izard, J.C., Mohammad, R., Mossalayi, 0D.M. and Kolb, J.P. (2002): Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol 117: 842-851
- Sharma, S., Misra, C. S., Arumugam, S., Roy, S., Shah, V., Davis, J. A., Shirumalla, R. K., Ray, A. (2011). Anti-sdiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes. Phytother. Res. 25, 67-73. http://dx.doi.org/10.1002/ptr.3221
- Soares, D.G., Andreazza, A.C., Salvador M. (2003): Sequestering ability of butylated hydrooxytoluene, propyl gallate, resveratrol, and vitamin C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems. J Agric Food Chem 51(4): 1077–1080. http://dx.doi.org/10.1021/jf020864z
- Soleas, G.J., Diamandis, E.P., Goldberg, D.M.(1997): Resveratrol: a molecule whose time has come? And gone? ClinBiochem 30 (2): 91–113. http://dx.doi.org/10.1016/S0009-9120(96)00155-5
- Su, H. C., Hung, L. M., Chen, J. K., (2006): Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290: E1339– E1346. http://dx.doi.org/10.1152/ajpendo.00487.2005
- Sun, A.Y., Wang Q., Simonyi, A. and Sun G.Y. (2010): Resveratrol as a therapeutic agent for the neurodegenerative diseases. MolNeurobiol 41:375–383. http://dx.doi.org/10.1007/s12035-010-8111-y
- Terzibasi, E., Valenzano, D.R., and Cellerino, A. (2007): The short lived fish Nothobranchiusfurzeri as a new model system for ageing studies. Exp. Gerontol. 42:81-89
- Tissenbaum, H.A. and Guarente, L. (2001): Increased dosage of Sir-2 gene extends lifespan in Caenorhabiditis elegans. Nature 410:227-230. http://dx.doi.org/10.1038/35065638
- Valenzano, D.R. and Cellerino,A. (2006): Resveratrol and the pharmacology of ageing. : A new vertebrate model to validate an old molecule. Cell Cycle 5: 1027-1032. http://dx.doi.org/10.4161/cc.5.10.2739
- Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, A., Lubahn, D., Sun, G. Y., Sun, A.Y., (2002): Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958:439- 447. http://dx.doi.org/10.1016/S0006-8993(02)03543-6
- Wang, Q., Yu, S., Simonyi, A., Rottinghaus, G., Sun, G. Y., Sun, A. Y., (2004): Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem. Res. 29: 2105-2112. http://dx.doi.org/10.1007/s11064-004-6883-z
- Wang, Z., Chen, Y., Labinskyy, N., Heish, T.C., Ungvari, Z., and Wu, J.M. (2006): Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts. Biochem. Biophys. Res. Commun. 346: 367–376. http://dx.doi.org/10.1016/j.bbrc.2006.05.156
- Wang, Z., Zou, J., Huang, Y., Cao, K., Xu, Y. and Wu, J.M. (2002): Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin. Med. J. (Engl). 115: 378–380.
- Wolter, F., Akoglu, B., Clausnitzer, A. and Stein, J. (2001): Down regulation of the cyclin D1/ Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 131: 2197-2203
- Zenser, T.V., Mattammal, M.B., Wise, R.W., Rice, J.R., Davis, B.B (1983): Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical arcinogenesis. J PharmacolExpTher. 227(3):545–550.
- Zou, J., Huang, Y., Chen, Q., Wang, N., Cao, K., Hsieh, T.C. and Wu, J.M. (1999): Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells. Int. J. Oncol. 15: 647–651.
- Zou, J., Huang, Y., Chen, Q., Wei, E., Cao, K. and Wu, J.M. (2000): Effects of resveratrol on oxidative odification of human low density lipoprotein. Chin. Med. J. (Engl). 113: 99–102.
- Zou, J.G., Huang, Y.Z., Chen, Q., Wei, E.H., Heish, T.C., and Wu, J.M. (1999): Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein. Biochem. Mol. Biol. Int. 47: 1089–1096.
How to Cite
Sanjai Saxena, Anugya Srivastava. Resveratrol: Biological Activities and Therapeutic Potential.
J. Pharm. Technol. Res. Manag.. 2014, 02, 145-157
